Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
39.1M
-
Shares change
-
+6.72M
-
Total reported value, excl. options
-
$226M
-
Value change
-
+$45.3M
-
Put/Call ratio
-
0.27
-
Number of buys
-
58
-
Number of sells
-
-24
-
Price
-
$5.79
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q3 2022
100 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q3 2022.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.1M shares
of 148M outstanding shares and own 26.36% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.78M shares), ORBIMED ADVISORS LLC (3.66M shares), BVF INC/IL (3.14M shares), Deep Track Capital, LP (2.64M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.25M shares), VANGUARD GROUP INC (1.67M shares), BOXER CAPITAL, LLC (1.4M shares), CITADEL ADVISORS LLC (1.13M shares), Rubric Capital Management LP (989K shares), and GREAT POINT PARTNERS LLC (955K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.